Ethzilla Corp. (ETHZ)
NASDAQ: ETHZ
· Real-Time Price · USD
2.51
0.18 (7.73%)
At close: Sep 26, 2025, 3:59 PM
2.58
2.79%
After-hours: Sep 26, 2025, 07:56 PM EDT
Company Description
ETHZilla operates in digital asset management, gaming, and entertainment.
The Company is developing an Ether (ETH) accumulation vehicle to serve as a benchmark for on-chain treasury management among public companies, supported by Electric Capital and a DeFi Council of industry experts.
Its strategy targets yield generation beyond traditional ETH staking while advancing gaming initiatives and pursuing monetization of legacy biotechnology assets from its origins as a biotech company.
Ethzilla Corp.
| Country | United States |
| IPO Date | Jun 27, 2017 |
| Industry | Asset Management - Cryptocurrency |
| Sector | Financial Services |
| Employees | 4 |
| CEO | Lloyd Blair Jordan |
Contact Details
Address: Building 4 Palo Alto, California United States | |
| Website | https://180lifesciences.com |
Stock Details
| Ticker Symbol | ETHZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001690080 |
| CUSIP Number | 68236V104 |
| ISIN Number | US68236V3024 |
| Employer ID | 81-3832378 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Lloyd Blair Jordan L.L.B., M.B.A. | Chief Executive Officer & Director |
| Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder & Director |
| Eric R. Van Lent | CAO, Principal Accounting & Financial Officer |
| Prof. Jagdeep Nanchahal M.D., Ph.D. | Co-Founder & Chairman of Clinical Advisory Board |
| Sir Marc Feldman Ph.D. | Co-Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 25, 2025 | SCHEDULE 13G | Filing |
| Sep 25, 2025 | 8-K/A | [Amend] Current Report |
| Sep 22, 2025 | 8-K | Current Report |
| Sep 19, 2025 | DEFA14A | Filing |
| Sep 19, 2025 | 8-K | Current Report |
| Sep 15, 2025 | D | Filing |
| Sep 15, 2025 | 8-K | Current Report |
| Sep 08, 2025 | 8-K | Current Report |
| Sep 05, 2025 | DEF 14A | Filing |
| Sep 05, 2025 | 8-K | Current Report |